It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis (DVT), a ...
To date, the optimal dosing strategy for VTE prophylaxis in critically ill, morbidly obese patients has not been determined. [20] These patients have generally been excluded from participation in ...
Despite its limitations, unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). Several small studies have suggested that intravenous ...
June 14, 2010 (Barcelona, Spain) — Major venous thromboembolism (VTE) and VTE-related mortality occurred in 2.2% of patients receiving oral dabigatran and in 4.2% of patients receiving subcutaneous ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — Treatment with 30 days of low-dose apixaban was no more effective than a shorter course of enoxaparin ...
Objectives: To compare the safety and effectiveness of two different thromboprophylactic protocols in the management of patients with spinal cord injury – one using heparin/warfarin and the other ...
Factor XIa inhibitors for the prevention and treatment of venous and arterial thromboembolism may be more effective and result in less bleeding than conventional anticoagulants. Additional data are ...
It is indicated alone or in combination with warfarin to prevent and treat blood clots in the leg. It is a low molecular weight heparin. Enoxaparin is indicated for preventing and treating blood clots ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback